These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 31003878)

  • 1. Characterizing patient-clinician chemotherapy-induced peripheral neuropathy assessment and management communication approaches.
    Knoerl R; Smith EML; Han A; Doe A; Scott K; Berry DL
    Patient Educ Couns; 2019 Sep; 102(9):1636-1643. PubMed ID: 31003878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the efficacy of an electronic symptom assessment and self-care intervention to preserve physical function in individuals receiving neurotoxic chemotherapy.
    Knoerl R; Weller E; Halpenny B; Berry D
    BMC Cancer; 2018 Dec; 18(1):1203. PubMed ID: 30514351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the impact of a decision support algorithm to improve clinicians' chemotherapy-induced peripheral neuropathy assessment and management practices: a two-phase, longitudinal study.
    Knoerl R; Mazzola E; Hong F; Salehi E; McCleary N; Ligibel J; Reyes K; Berry DL
    BMC Cancer; 2021 Mar; 21(1):236. PubMed ID: 33676431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling.
    Kolb NA; Smith AG; Singleton JR; Beck SL; Stoddard GJ; Brown S; Mooney K
    JAMA Neurol; 2016 Jul; 73(7):860-6. PubMed ID: 27183099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy.
    Molassiotis A; Cheng HL; Lopez V; Au JSK; Chan A; Bandla A; Leung KT; Li YC; Wong KH; Suen LKP; Chan CW; Yorke J; Farrell C; Sundar R
    BMC Cancer; 2019 Feb; 19(1):132. PubMed ID: 30736741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evaluation of changes in peripheral neuropathy and quality-of-life using low-frequency electrostimulation in patients treated with chemotherapy for breast cancer: a study protocol.
    Jang CE; Jung MS; Sohn EH; Kim M; Yoo HS; Bae K; Kim JR; Lee JS
    Trials; 2018 Sep; 19(1):526. PubMed ID: 30268158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy.
    Molassiotis A; Cheng HL; Leung KT; Li YC; Wong KH; Au JSK; Sundar R; Chan A; Ng TR; Suen LKP; Chan CW; Yorke J; Lopez V
    Brain Behav; 2019 Jun; 9(6):e01312. PubMed ID: 31063261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring Patients' Understanding of Chemotherapy-Induced Peripheral Neuropathy.
    Knoerl R; Berry DL; Meyerhardt J; Reyes K; Salehi E; Gewandter JS
    J Cancer Educ; 2023 Jun; 38(3):906-912. PubMed ID: 35927535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring Clinicians' Perspectives of Barriers to Chemotherapy-Induced Peripheral Neuropathy Assessment and Management in Oncology Practice: A Qualitative Analysis of Semi-structured Interviews.
    Knoerl R; Wallar J; Fox E; Hong F; Salehi E; McCleary N; Ligibel JA; Reyes K; Berry DL
    Cancer Nurs; 2023 Mar-Apr 01; 46(2):103-110. PubMed ID: 35283473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying trajectories and predictors of chemotherapy-induced peripheral neuropathy symptoms, physical functioning, and falls across treatment and recovery in adults treated with neurotoxic chemotherapy: the PATTERN observational study protocol (NCT05790538).
    Winters-Stone KM; Krasnow SM; Horak FB; Mancini M; Cameron MH; Dieckmann NF; Stoyles SA; Roeland EJ
    BMC Cancer; 2023 Nov; 23(1):1087. PubMed ID: 37946117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining the Impact of a Web-Based Intervention to Promote Patient Activation in Chemotherapy-Induced Peripheral Neuropathy Assessment and Management.
    Knoerl R; Lee D; Yang J; Bridges C; Kanzawa-Lee G; Lita Smith G; Lavoie Smith EM
    J Cancer Educ; 2018 Oct; 33(5):1027-1035. PubMed ID: 28265863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reflexology in the management of chemotherapy induced peripheral neuropathy: A pilot randomized controlled trial.
    Kurt S; Can G
    Eur J Oncol Nurs; 2018 Feb; 32():12-19. PubMed ID: 29353627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial.
    Lu W; Giobbie-Hurder A; Freedman RA; Shin IH; Lin NU; Partridge AH; Rosenthal DS; Ligibel JA
    Oncologist; 2020 Apr; 25(4):310-318. PubMed ID: 32297442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-Reported Severity, Characteristics, and Functional Limitations of Chemotherapy-Induced Peripheral Neuropathy.
    Knoerl R; Mazzola E; Hong F; Salehi E; McCleary N; Ligibel J; Reyes K; Berry DL
    Pain Manag Nurs; 2022 Aug; 23(4):532-540. PubMed ID: 34972658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.
    Kleckner IR; Kamen C; Gewandter JS; Mohile NA; Heckler CE; Culakova E; Fung C; Janelsins MC; Asare M; Lin PJ; Reddy PS; Giguere J; Berenberg J; Kesler SR; Mustian KM
    Support Care Cancer; 2018 Apr; 26(4):1019-1028. PubMed ID: 29243164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lived experiences and support needs of women who developed chemotherapy-induced peripheral neuropathy following treatment for breast and ovarian cancer.
    Tanay MA; Armes J
    Eur J Cancer Care (Engl); 2019 May; 28(3):e13011. PubMed ID: 30790382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redefining chemotherapy-induced peripheral neuropathy through symptom cluster analysis and patient-reported outcome data over time.
    Wang M; Cheng HL; Lopez V; Sundar R; Yorke J; Molassiotis A
    BMC Cancer; 2019 Nov; 19(1):1151. PubMed ID: 31775665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of behavioural and exercise interventions for the prevention and management of chemotherapy-induced peripheral neuropathy symptoms.
    Tanay MAL; Armes J; Moss-Morris R; Rafferty AM; Robert G
    J Cancer Surviv; 2023 Feb; 17(1):254-277. PubMed ID: 33710510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient perceptions of altering chemotherapy treatment due to peripheral neuropathy.
    Hertz DL; Tofthagen C; Rossi E; Bernasconi DP; Lim J; Carlson M; Sheffield KE; Nekhlyudov L; Grech L; Von Ah D; Mayo SJ; Ruddy KJ; Chan A; Alberti P; Lustberg MB; Tanay M
    Support Care Cancer; 2023 Dec; 32(1):48. PubMed ID: 38129602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroacupuncture use for treatment of taxane-induced peripheral neuropathy in patients with breast cancer: protocol for a pilot, randomised, blinded, sham-controlled trial (EA for CIPN).
    Choi V; Park SB; Lacey J; Kumar S; Heller G; Grimison P
    BMJ Open; 2024 Jan; 14(1):e076391. PubMed ID: 38195173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.